Curiosity question. Could the seemingly elongated wait for unblinded be a blessing in disguise? The extra 2 weeks should also afford us the 42 day stats recommended for interim by the dsmc no? That way we can pull a gilead and change endpoint to 42 days vs 28 which instead of being a lame hospital stay endpoint would show by changing endpoint our patients live longer than placebo?? I don't know if this is possible. Just a thought.